Uso de imunoterapia no tratamento do câncer de mama: relato de caso

Abstract

Breast cancer is the neoplasm that most affects women in the world, and with the help of new research, immunotherapy comes to bring new hopes. The purpose of this case study is to demonstrate new technologies with positive results in the treatment of advanced triple negative or metastatic breast cancer. This is a descriptive, case-report study on the application of immunotherapy in the treatment of breast cancer. This positive result was obtained through a study called Impassion 130, where women were divided into two groups, one group received nab-paclitaxel and atezolizumab and the other with nab pacitaxel and placebo. However, the patient is using atezolizumab and paclitaxel, where she is being followed and with positive responses in her treatment. The treatment for metastatic breast cancer, the immunotherapeutic atezolizumab and the chemotherapy paclitaxel was approved, the results are positive and encouraging, bringing increased survival and fewer side effects to patients.